KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Work In Process (2018 - 2025)

Rigel Pharmaceuticals has reported Work In Process over the past 8 years, most recently at $5.5 million for Q3 2025.

  • Quarterly results put Work In Process at $5.5 million for Q3 2025, up 202.98% from a year ago — trailing twelve months through Sep 2025 was $5.5 million (up 202.98% YoY), and the annual figure for FY2024 was $1.2 million, down 34.65%.
  • Work In Process for Q3 2025 was $5.5 million at Rigel Pharmaceuticals, up from $2.0 million in the prior quarter.
  • Over the last five years, Work In Process for RIGL hit a ceiling of $6.0 million in Q2 2024 and a floor of $162000.0 in Q4 2021.
  • Median Work In Process over the past 5 years was $1.5 million (2022), compared with a mean of $2.0 million.
  • Biggest five-year swings in Work In Process: plummeted 86.38% in 2021 and later skyrocketed 1541.36% in 2022.
  • Rigel Pharmaceuticals' Work In Process stood at $162000.0 in 2021, then skyrocketed by 1541.36% to $2.7 million in 2022, then fell by 29.45% to $1.9 million in 2023, then plummeted by 34.65% to $1.2 million in 2024, then soared by 347.55% to $5.5 million in 2025.
  • The last three reported values for Work In Process were $5.5 million (Q3 2025), $2.0 million (Q2 2025), and $1.1 million (Q1 2025) per Business Quant data.